Background The objective was to characterise the process and consequences of eosinophil activation and lysis in patients with chronic eosinophilic pneumonia and to compare them with those in patients with eosinophil pulmonary infiltrates from other causes.
Results
In the four patients with chronic eosinophilic pneumonia, ultrastructural studies demonstrated numerous lysed eosinophils. Further, three released eosinophil proteins were detected in distinct cytoplasmic structures in alveolar macrophages. These features were not found in the four patients with eosinophilic pulmonary infiltrates from other causes. Conclusion Eosinophils in chronic eosinophilic pneumonia show signs of activation with release of eosinophil proteins. The appearance of three ofthese eosinophil proteins in different macrophage compartments suggests that macrophage uptake, with or without intracellular transport of released eosinophil proteins, involves separate mechanisms. This interaction does not lead to macrophage lysis, however, and one or more of these eosinophil proteins might directly affect macrophage function. (Thorax 1993; 48:57-62) Chronic eosinophilic pneumonia is characterised by a high eosinophil count in bronchoalveolar lavage fluid,' 2 severe constitutional symptoms and pulmonary infiltrates in the upper lobes.34 Steroid therapy can lead to a dramatic response, but prolonged therapy is frequently required to avoid recurrence."
Morphological, biochemical, and functional studies of eosinophils from blood and tissues of patients with diseases related to eosinophils have shown that they differ from normal eosinophils in several ways.8 A predominant "hypodense" alveolar eosinophil population has been found in lavage fluid of patients with active chronic eosinophilic pneumonia.' This density difference ("hypodense" versus "normodense" eosinophils) identifies eosinophil subpopulations with differing immunological and metabolic characteristics.9 Past studies have suggested that tissue eosinophils in patients with chronic eosinophilic pneumonia are activated, but the interpretation of these studies was limited as they were performed on purified blood or lavage fluid eosinophil populations and, therefore, did not reveal the fate of released eosinophil granule components.
Analyses of ultrastructural features in chronic eosinophilic pneumonia have shown alterations in eosinophil fine structure,'" 1 and the presence of eosinophil granules as well as Charcot-Leyden crystals in pulmonary macrophages,"2 13 The purpose of this study was to localise eosinophil proteins in cells of bronchoalveolar lavage fluid at the ultrastuctural level and to assess eosinophil changes and possible interactions with other cells in fluid obtained by bronchoalveolar lavage in patients with chronic eosinophilic pneumonia. Therefore we combined electron microscopy and immunogold detection of eosinophilic cationic protein, major basic protein, and Charcot-Leyden crystal (CLC) proteins to study the cells obtained by bronchoalveolar lavage from four patients with chronic eosinophilic pneumonia and from four others with eosinophilic pulmonary infiltrates due to other causes. All were nonsmokers. bovine serum albumin. Total cell counts were determined using a haemocytometer. A cytocentrifuge slide was made and stained using the May-Grunwald-Giesma stain for differential cell counting. The remaining cells were centrifuged at 500 g for 10 minutes, and the pellet was fixed in cacodylate buffer containing 1% glutaraldehyde at 4 'C.
MEASUREMENT OF ECP IN BRONCHOALVEOLAR LAVAGE FLUID
For three patients with chronic eosinophilic pneumonia (cases 1, 3, and 4), the four patients with eosinophilic pulmonary infiltrates from other causes, and three healthy control subjects, levels of ECP in bronchoalveolar lavage fluid were measured in duplicate with a radioimmunoassay, using the method recommended by the manufacturer (ECP RIA Pharmacia, Uppsala, Sweden).
ELECTRON MISCROSCOPY
The pellet was cut into small specimens after aldehyde fixation. This was followed by osmium tetroxide fixation. Half of the specimens were embedded in araldite and processed further for conventional electron microscopy. The other specimens were embedded in Lowicryl K4M for immunocolloidal gold labelling. temperature, sections were thoroughly washed with TBS, postfixed for 10 minutes in TBS containing 2% glutaldehyde, and washed again with distilled water. Finally, the sections were subjected to silver enhancement according to a modification of Danscher's silver lactate hydroquinone physical developer.
The specificity of the immunostaining was tested by omitting the first antibody and substituting the specific antibodies with the preimmune serum or with unrelated antibodies whose labelling had been analysed previously.20
Lowicryl sections were stained with uranyl acetate and lead citrate before examination with a Philips EM 420 electron microscope.
Results
In all four cases of chronic eosinophilic pneumonia, bronchoalveolar lavage fluid showed similar features for macrophage fine structure, extracellular eosinophil components and distribution of MBP, ECP and CLC into macrophage cytoplasmic compartments. Comparative studies performed in the four control cases of eosinophilic pulmonary infiltrates showed that free eosinophil granules were only observed in case 6; they were few and extracellular gold particles were only observed with anti-CLC antibodies. In the three other cases, a few intracytoplasmic granules had a central core of irregular density, but no extracellular gold particles were observed with any of the three antibodies.
MEASUREMENT OF ECP IN BRONCHOALVEOLAR LAVAGE FLUID
The release of ECP in to extracellular space could not be quantified with immunogold labelling, but measurement of ECP levels in bronchoalveolar lavage fluid showed high values in chronic eosinophilic pneumonia (31 ,ug/ml; range 29-33 hg/ml), compared with the control subjects with eosinophilic pulmonary infiltrate (8 jug/ml; range 5-10 hg/ml) (table), and with the three normal subjects (2-7 ,ug/ml; range 2-3 hg/ml). showed that this granular protein was distributed within the macrophage cytoplasm, but only on pseudomyelinic structures, and not on Charcot-Leyden crystals nor in vacuoles with a granular content (fig 2a) .
Staining with anti-ECP antibodies showed that this component of the granule matrix was selectively distributed on the macrophage vacuoles with a coarse granular content (fig 2b) but neither on Charcot-Leyden crystals nor on pseudomyelinic structures. With anti-CLC antibodies, gold particles were concentrated on macrophage vacuoles with a well delineated crystal (fig 2c) . They were also found on macrophage vacuoles with a dense, homogeneous content (figs 3a and b), but neither on granular vacuoles (fig 3a) nor on pseudomyelinic structures (fig 3b) .
In the four control cases of eosinophilic pulmonaryikifiltrates, no gold particles could be detected in the macrophages in the bronchoalveolar lavage fluid after incubation with anti-MBP, anti-ECP, or anti-CLC antibodies.
Discussion
This analysis of bronchoalveolar lavage fluid in four cases of chronic eosinophilic pneumonia studied eosinophils mixed with alveolar macrophages, as opposed to former studies on purified eosinophil populations. It showed important ultrastructural alterations of eosinophils, the release of three eosinophil proteins, and the distribution of these three proteins in different macrophage compartments. These features were not observed in the four control patients with eosinophil pulmonary infiltrate. Cytoplasmic damage of eosinophils in chronic eosinophilic pneumonia has been previously reported histologically as part of "eosinophilic microabscess" in the lung,7 and ultrastructurally as numerous free eosinophil granules.12 13 In vitro, a predominant "hypodense" eosinophil population has been seen in bronchoalveolar lavage fluid of active cases, suggesting an activation process of eosinophils in this disease.1 In the four cases of chronic eosinophilic pneumonia in this study, eosinophil activation was further suggested by the presence of numerous free granules, release of three eosinophil proteins, and a significant increase in the concentration of ECP in bronchoalveolar lavage fluid compared with the control cases and the three normal controls.
Another type of eosinophil activation is the "piecemeal degranulation" observed in human cord blood eosinophils cultured with interleukin 5.2i This type of activation with intact cytoplasm containing electronlucent granules has also been found in eosinophilic gastritis,22 coeliac disease,23 and Crohn's disease. 24 We did not find any evidence of this type of eosinophil activation in our patients with chronic eosinophilic pneumonia. In this disease, the release of cationic proteins appears to result from the liberation of the whole granule following eosinophil lysis. Eosinophil degranulation associated with cell lysis, as seen in chronic eosinophilic pneumonia, may reflect a relatively higher These three proteins might be the effectors of a possible pathological role of eosinophil in chronic eosinophilic pneumonia. 25 Although it has been proposed that eosinophils cause tissue damage in chronic eosinophilic pneumonia,'2it has not been demonstrated that the number or state of activation of eosinophils in bronchoalveolar lavage fluid are related to impaired lung function in this disease in the way they are in idiopathic pulmonary fibrosis.30"3 In chronic eosinophilic pneumonia, the uptake and selective distribution of the three eosinophil proteins in different macrophage compartments might protect the alveolar wall by preventing the high extracellular concentration of eosinophil proteases which is necessary for these proteins to exert their cytotoxic effects on lung parenchyma. 32 Our results emphasise the high degree of activation of eosinophils in chronic eosinophilic pneumonia and their interaction with alveolar macrophages. Although many functions have been proposed, evidence now suggests that, as effector cells, eosinophils can have roles that are both beneficial and detrimental to the host.33 Eosinophils may have a collaborative role with macrophages involved in lung immune response in chronic eosinophilic pneumonia. 
